| BRAFi | BRAF inhibitor |
| AJCC | American Joint Committee on Cancer |
| MEKi | Mitogen-activated protein inhibitor |
| cSCCs | Cutaneous squamous cell carcinomas |
| UV | Ultraviolet light |
| MAPK | Mitogen-activated protein kinase |
| WT | Wild-type |
| HPV | Human papillomavirus |
| tg | Transgenic |
| MmuPV1 | Mus musculus papillomavirus 1 |
| CMC | Carboxymethyl cellulose |
| FFPE | Formalin-fixed and paraffin-embedded |
| M | MmuPV1-infected mice |
| B | BRAF-inhibitor-treated mice |
| U | UVB-irradiated mice |
| Ø | Vehicle-treated mice |
| MBU | MmuPV1-infected, BRAFi-treated, UVB-irradiated mice |
| MB | MmuPV1-infected, BRAFi-treated mice |
| MU | MmuPV1-infected, UVB-irradiated mice |
| BU | BRAF-inhibitor-treated and UVB-irradiated mice |
| DMSO | Dimethyl sulfoxide |
| K17 | Keratin 17 |